0
Tag "sandoz"
EC approves subcutaneous route of administration in Sandoz biosimilar, Binocrit
Sandoz, a Novartis division and the global leader in biosimilars, announced today that the European Commission (EC) has approved a type II variation for the addition of a subcutaneous (s.c.)